When Florida Surgeon General Dr. Joseph A. Ladapo and the Florida Department of Health issued guidance on July 24, 2026 recommending against the use of psychotropic drugs to treat children ages 5 to 17 for depression, anxiety, and attention-deficit-related disorders, CCHR Florida called it an important step toward protecting children from unnecessary psychiatric drugging (CCHR Florida). The guidance directs providers toward comprehensive evaluation and lifestyle interventions before medication, and it calls for careful deprescribing for children already on these drugs (Florida Department of Health guidance).

But guidance is not law. It carries no enforcement mechanism, and it does not require a single prescriber to change a single prescription. If Florida is serious about protecting children from psychiatric drugging, that seriousness has to show up in the statute books — and this year, it didn’t.

A bill that could have mattered died quietly in March

Three weeks before the Surgeon General’s guidance was issued, a different, far quieter process was playing out in Tallahassee. CS/CS/CS/SB 560, sponsored by Sen. Ileana Garcia, and its House companion, CS/HB 763, sponsored by Rep. Dana Trabulsy, set out to change how Florida documents and reviews psychotropic drug prescriptions for children in the legal custody of the Department of Children and Families (Florida Senate, SB 560 history; Florida Senate, HB 763 history).

The bill passed the full Senate unanimously, 37–0, on March 4, 2026. Then it went to the House — and died in committee on March 13, 2026, without a floor vote (Florida Senate, SB 560 history; Florida Senate, HB 763 history).

It’s worth being clear-eyed about what SB 560 actually would have done. It was not a bill to restrict psychotropic drugging of children in state care. According to the Senate’s own bill analysis, it would have reduced how often a new medical report is required when a child’s prescription continues unchanged, treated physicians in the same group practice as a single prescriber for reporting purposes, and replaced the requirement that a physician provide pharmacies with a signed attestation of parental consent with a simple copy of the consent documentation (Florida Senate bill analysis, CS/CS/CS/SB 560). In other words, the one piece of legislation lawmakers actually voted on this year moved toward less paperwork around psychotropic prescribing for foster children, not more scrutiny of whether those children should be on the drugs at all.

That bill died. Which means Florida enters the second half of 2026 with a Surgeon General’s guidance recommending against routine psychotropic drugging of children, sitting alongside a 21-year-old statute, Section 39.407, Florida Statutes, enacted in 2005, that still governs how those drugs actually get authorized for children in state custody (Florida Statutes, s. 39.407). Nothing about how that law works changed this year.

The gap between guidance and law is not theoretical

Florida’s own data shows why this gap matters. As of April 2026, 1,909 children in out-of-home care statewide, 13.72% of all children in Florida’s foster care system, had an active prescription for one or more psychotropic medications (Florida Department of Children and Families, Psychotropic Medications Report). A federal audit released by the U.S. Department of Health and Human Services’ Office of Inspector General found that Florida did not consistently comply with its own documentation requirements: of a sample of foster children prescribed psychotropic drugs, dozens had medications not properly recorded, missing medication logs, or missing authorization records in the state’s own case-management system (HHS Office of Inspector General). A federal GAO review separately found that Florida foster children were prescribed psychotropic drugs at 2.7 to 4.5 times the rate of non-foster children on Medicaid (U.S. Government Accountability Office), and a 2026 peer-reviewed study found Florida foster children are prescribed psychotropic medication at nearly seven times the rate of children with Medicaid who are not in foster care — frequently without any documented mental health diagnosis (Journal of the American Academy of Child & Adolescent Psychiatry).

None of that changed because of a guidance document. Compliance problems that federal auditors flagged, and prescribing patterns that peer-reviewed researchers have quantified, are governed by statute, licensing rules, and Medicaid policy; not by a memo from the Department of Health, however welcome. And the one bill that touched that statute this year didn’t strengthen it; it streamlined paperwork around it, and even that couldn’t get a House vote.

What CCHR Florida is asking for next

“The Surgeon General’s guidance says what needed to be said. That psychotropic drugs should not be the first response to a struggling child,” said Diane Stein, President of CCHR Florida. “But guidance can be ignored with no consequence. The children in Florida’s foster care system who are already being prescribed these drugs at multiple times the rate of other kids are protected by statute, not by memo. If lawmakers agree with the Surgeon General, the 2027 session is where that agreement has to become enforceable law with real evaluation requirements, real informed-consent enforcement, and real deprescribing protocols written into Section 39.407 itself, not just recommended alongside it.”

CCHR Florida is calling on the Legislature to use its 2027 session to do what guidance alone cannot: give the standards in the Surgeon General’s recommendation the force of law. A recommendation is a good first move. A statute is what actually protects a child.